IDO1 and Cognitive impairment: The results from Watne et al. (4) also suggest that there is therapeutic potential for the use of IDO inhibition in various circumstances, including in the delirious patient population, for mitigation of sleep-wake cycle disturbances, for delaying neurodegenerative disorder progression, and for lessening neurologic damage and cognitive impairments from radiation therapy.